MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST

System, Test, Tumor Marker, Monitoring, Bladder

VYSIS

The following data is part of a premarket notification filed by Vysis with the FDA for Modification To Vysis Urovysion Bladder Cancer Recurrence Test.

Pre-market Notification Details

Device IDK033982
510k NumberK033982
Device Name:MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST
ClassificationSystem, Test, Tumor Marker, Monitoring, Bladder
Applicant VYSIS 3100 WOODCREEK DRIVE Downers Grove,  IL  60515 -5400
ContactKerry J Flom
CorrespondentKerry J Flom
VYSIS 3100 WOODCREEK DRIVE Downers Grove,  IL  60515 -5400
Product CodeMMW  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-12-23
Decision Date2004-01-22
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.